Pathogenic Age-Associated B Cells for Environmental and Agricultural Applications
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of targeting pathogenic age-associated B cells to develop novel applications in environmental monitoring, agricultural optimization, and personalized skincare, expanding the original patent's scope beyond autoimmune disease treatment.
Background and Problem Solved
The original patent focused on treating autoimmune diseases by targeting pathogenic age-associated B cells. However, the limitations of this approach lie in its narrow focus on human health. This new inventive concept addresses the need for innovative solutions in environmental monitoring, agricultural optimization, and personalized skincare, where the unique properties of pathogenic age-associated B cells can be harnessed to create impactful technologies.
Detailed Description of the Inventive Concept
The new inventive concept comprises a range of applications that utilize pathogenic age-associated B cells as biosensors, biostimulants, or biomarkers. In environmental monitoring, these biosensors detect and respond to specific pollutants, enabling real-time monitoring of environmental pollution. In agricultural optimization, the biostimulants enhance plant growth and resistance to disease, increasing crop yields. In personalized skincare, the biomarkers identify specific skin types and conditions, enabling the creation of customized skincare products. These applications are made possible by the unique properties of pathogenic age-associated B cells, which can be engineered to respond to specific stimuli and provide accurate, real-time data.
Novelty and Inventive Step
The new claims introduce a paradigm shift in the application of pathogenic age-associated B cells, moving beyond autoimmune disease treatment to address pressing issues in environmental monitoring, agricultural optimization, and personalized skincare. The inventive step lies in recognizing the potential of these cells to serve as biosensors, biostimulants, or biomarkers, and developing novel systems and methods that harness their unique properties.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include using pathogenic age-associated B cells to detect and respond to other environmental pollutants, or to optimize crop yields in specific agricultural contexts. Variations could also involve integrating these cells with other technologies, such as machine learning algorithms or IoT devices, to create more sophisticated monitoring and optimization systems.
Potential Commercial Applications and Market
The potential commercial applications of this inventive concept are vast, with opportunities in environmental monitoring, agricultural optimization, and personalized skincare. The target industries include environmental consulting, agricultural technology, and cosmetics, with potential partnerships with companies, research institutions, and government agencies.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Cellular biotechnology with specialization in immunological cell engineering, biomarker development, and adaptive cellular systems with expertise in molecular biology, genetic engineering, and cellular signal transduction
Person of Ordinary Skill (PHOSITA) Profile
A researcher or biotechnologist with advanced degree (PhD/MS) in immunology or molecular biology, capable of understanding cellular manipulation techniques, signal transduction pathways, and cross-disciplinary applications of cellular technologies
Obviousness Rationale
A PHOSITA would recognize that pathogenic age-associated B cells represent a versatile cellular platform with inherent signaling and response capabilities that can be readily adapted across multiple domains beyond their original medical context. The source patent's fundamental disclosure of cellular targeting and manipulation provides a clear technological foundation for exploring alternative applications in environmental monitoring, agricultural optimization, and diagnostic technologies. The PTD's variations represent predictable extensions of the core cellular engineering principles established in the original patent.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,563 |
|---|---|
| Title | Inhibition of expansion and function of pathogenic age-associated B cells and use for the prevention and treatment of autoimmune disease |
| Assignee(s) | NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED, MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY |